Teriparatide

FDA Approved: * November 16, 2023
Pharm Company: * TEVA PHARMS USA
Category: Osteoporosis

Teriparatide is a form of parathyroid hormone (PTH) consisting of the first (N-terminus) 34 amino acids, which is the bioactive portion of the hormone. It is an effective anabolic (promoting bone formation) agent[3] used in the treatment of some forms of osteoporosis.[4] It is also occasionally used off-label to speed fracture healing. Teriparatide is identical to a portion of human parathyroid hormone and intermittent use activates osteoblasts more than osteoc... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
2 Discussions

Dosage List

Teriparatide 250 ug/ml Subcutaneous Injection, Solution
NDC: 0093-1106
Labeler:
Teva Pharmaceuticals USA, Inc.
Teriparatide 250 ug/ml Subcutaneous Injection, Solution
NDC: 47781-652
Labeler:
Alvogen, Inc.
Teriparatide 250 ug/ml Subcutaneous Injection, Solution
NDC: 60505-6188
Labeler:
Apotex Corp.
Teriparatide 250 ug/ml Subcutaneous Injection, Solution
NDC: 66993-495
Labeler:
Prasco Laboratories

Related Brands

Drugs with the same active ingredients

Popular Topics

Teriparatide Pen Travel Bag

Does anyone know of a small travel bag for the Teriparatide pen, which will keep cool for long periods of time? I have r...

1 REPLY
How to use Forteo (Teriparatide) only twice a week

In Japan and Korea, teriparatide (generic of Forteo) is available for once-a-week or twice-a-week-injections -- instead ...

teriparatide

this drug is also called forteo and it is for osteosporosis...